John Hoeven bought Dr Pepper Snapple Group, Inc. (DPS)
John Hoeven (R-ND), a U.S. Senator, has disclosed 1 trade in Dr Pepper Snapple Group, Inc. (DPS) since 2017, a single purchase, worth an estimated $175K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: John Hoeven bought $100,001 - $250,000 of Dr Pepper Snapple Group, Inc. (DPS) on July 26, 2017. Since that trade, DPS is up +0.00% against the S&P 500 up +238.34%, an outperformance of -238.34%.
Data updated
John Hoeven's DPS trades vs the price
DPS is up +0.00% since John Hoeven bought on July 26, 2017, versus +238.34% for the S&P 500.
Performance since this trade
All John Hoeven DPS trades
John Hoeven & DPS trading FAQ
Is it legal for John Hoeven to trade Dr Pepper Snapple Group, Inc. (DPS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Dr Pepper Snapple Group, Inc. (DPS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did John Hoeven buy DPS?
John Hoeven disclosed a purchase of $100,001 - $250,000 of Dr Pepper Snapple Group, Inc. (DPS) on July 26, 2017, according to public STOCK Act filings.
How has DPS performed since John Hoeven's trade?
Since John Hoeven bought DPS on July 26, 2017, the stock is up +0.00%, versus +238.34% for the S&P 500 over the same period, an outperformance of -238.34%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional DPS trades?
Quantellect tracks every disclosed congressional trade in Dr Pepper Snapple Group, Inc. (DPS) on the Dr Pepper Snapple Group, Inc. congressional trading page, which aggregates filings across all members of Congress.
John Hoeven's DPS tradesAll congressional filings for Dr Pepper Snapple Group, Inc.John Hoeven's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.